Thursday, February 18, 2016

Molecular Psychiatry - Table of Contents alert Volume 21 Issue 3

If you are unable to see the message below, click here to view.
Molecular Psychiatry

TABLE OF CONTENTS

Volume 21, Issue 3 (March 2016)

In this issue
Image
News and Commentary
Expert Review
Immediate Communication
Original Articles
Erratum

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Translational Psychiatry is an online-only, open access journal exploring the translational pathway between research in neuroscience and conceptually novel treatments. The journal has an Impact Factor of 5.62.

Explore the benefits of submitting your next research article.

Image

Top

SKA2 methylation predicts reduced cortical thickness in prefrontal cortex

N Sadeh, J M Spielberg, M W Logue, E J Wolf, A K Smith, J Lusk, J P Hayes, E Sperbeck, W P Milberg, R E McGlinchey, D H Salat, W C Carter, A Stone, S A Schichman, D E Humphries and M W Miller

Mol Psychiatry 2016 21: 299; 10.1038/mp.2016.10

Full Text | PDF

News and Commentary

Top

Cleavage of p75 neurotrophin receptor is linked to Alzheimer’s disease

M V Chao

Mol Psychiatry 2016 21: 300-301; advance online publication, January 19, 2016; 10.1038/mp.2015.214

Full Text | PDF

Expert Review

Top

The dynamics of the stress neuromatrix OPEN

N Sousa

Mol Psychiatry 2016 21: 302-312; advance online publication, January 12, 2016; 10.1038/mp.2015.196

Abstract | Full Text | PDF

Immediate Communication

Top

Antidepressant action of ketamine via mTOR is mediated by inhibition of nitrergic Rheb degradation

M M Harraz, R Tyagi, P Cortés and S H Snyder

Mol Psychiatry 2016 21: 313-319; advance online publication, January 19, 2016; 10.1038/mp.2015.211

Abstract | Full Text | PDF

Original Articles

Top

A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder

M S Milak, C J Proper, S T Mulhern, A L Parter, L S Kegeles, R T Ogden, X Mao, C I Rodriguez, M A Oquendo, R F Suckow, T B Cooper, J G Keilp, D C Shungu and J J Mann

Mol Psychiatry 2016 21: 320-327; advance online publication, August 18, 2015; 10.1038/mp.2015.83

Abstract | Full Text | PDF

Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration OPEN

A Ferrés-Coy, M Galofré, F Pilar-Cuéllar, R Vidal, V Paz, E Ruiz-Bronchal, L Campa, Á Pazos, J R Caso, J C Leza, G Alvarado, A Montefeltro, E M Valdizán, F Artigas and A Bortolozzi

Mol Psychiatry 2016 21: 328-338; advance online publication, June 23, 2015; 10.1038/mp.2015.80

Abstract | Full Text | PDF

Gene expression in major depressive disorder

R Jansen, B W J H Penninx, V Madar, K Xia, Y Milaneschi, J J Hottenga, A R Hammerschlag, A Beekman, N van der Wee, J H Smit, A I Brooks, J Tischfield, D Posthuma, R Schoevers, G van Grootheest, G Willemsen, E J de Geus, D I Boomsma, F A Wright, F Zou, W Sun and P F Sullivan

Mol Psychiatry 2016 21: 339-347; advance online publication, May 26, 2015; 10.1038/mp.2015.57

Abstract | Full Text | PDF

Divergent responses of the amygdala and ventral striatum predict stress-related problem drinking in young adults: possible differential markers of affective and impulsive pathways of risk for alcohol use disorder

Y S Nikolova, A R Knodt, S R Radtke and A R Hariri

Mol Psychiatry 2016 21: 348-356; advance online publication, June 30, 2015; 10.1038/mp.2015.85

Abstract | Full Text | PDF

SKA2 methylation is associated with decreased prefrontal cortical thickness and greater PTSD severity among trauma-exposed veterans

N Sadeh, J M Spielberg, M W Logue, E J Wolf, A K Smith, J Lusk, J P Hayes, E Sperbeck, W P Milberg, R E McGlinchey, D H Salat, W C Carter, A Stone, S A Schichman, D E Humphries and M W Miller

Mol Psychiatry 2016 21: 357-363; advance online publication, September 1, 2015; 10.1038/mp.2015.134

Abstract | Full Text | PDF

Arc expression identifies the lateral amygdala fear memory trace OPEN

L A Gouty-Colomer, B Hosseini, I M Marcelo, J Schreiber, D E Slump, S Yamaguchi, A R Houweling, D Jaarsma, Y Elgersma and S A Kushner

Mol Psychiatry 2016 21: 364-375; advance online publication, March 24, 2015; 10.1038/mp.2015.18

Abstract | Full Text | PDF

Differential activation of immune/inflammatory response-related co-expression modules in the hippocampus across the major psychiatric disorders

S Kim, Y Hwang, M J Webster and D Lee

Mol Psychiatry 2016 21: 376-385; advance online publication, June 16, 2015; 10.1038/mp.2015.79

Abstract | Full Text | PDF

Role for neonatal D-serine signaling: prevention of physiological and behavioral deficits in adult Pick1 knockout mice

J Nomura, H Jaaro-Peled, E Lewis, P Nuñez-Abades, F Huppe-Gourgues, T Cash-Padgett, F Emiliani, M A Kondo, A Furuya, M A Landek-Salgado, Y Ayhan, A Kamiya, T Takumi, R Huganir, M Pletnikov, P O'Donnell and A Sawa

Mol Psychiatry 2016 21: 386-393; advance online publication, May 26, 2015; 10.1038/mp.2015.61

Abstract | Full Text | PDF

L-type Ca2+ channel blockade with antihypertensive medication disrupts VTA synaptic plasticity and drug-associated contextual memory

M Degoulet, C E Stelly, K-C Ahn and H Morikawa

Mol Psychiatry 2016 21: 394-402; advance online publication, June 23, 2015; 10.1038/mp.2015.84

Abstract | Full Text | PDF

Maternal dexamethasone exposure ameliorates cognition and tau pathology in the offspring of triple transgenic AD mice

A Di Meco, Y B Joshi, E Lauretti and D Praticò

Mol Psychiatry 2016 21: 403-410; advance online publication, June 16, 2015; 10.1038/mp.2015.78

Abstract | Full Text | PDF

GABA/Glutamate synaptic pathways targeted by integrative genomic and electrophysiological explorations distinguish autism from intellectual disability

F Bonnet-Brilhault, S Alirol, R Blanc, S Bazaud, S Marouillat, R-A Thépault, C R Andres, É Lemonnier, C Barthélémy, M Raynaud, A Toutain, M Gomot and F Laumonnier

Mol Psychiatry 2016 21: 411-418; advance online publication, June 9, 2015; 10.1038/mp.2015.75

Abstract | Full Text | PDF

Common polygenic risk for autism spectrum disorder (ASD) is associated with cognitive ability in the general population OPEN

T-K Clarke, M K Lupton, A M Fernandez-Pujals, J Starr, G Davies, S Cox, A Pattie, D C Liewald, L S Hall, D J MacIntyre, B H Smith, L J Hocking, S Padmanabhan, P A Thomson, C Hayward, N K Hansell, G W Montgomery, S E Medland, N G Martin, M J Wright, D J Porteous, I J Deary and A M McIntosh

Mol Psychiatry 2016 21: 419-425; advance online publication, March 10, 2015; 10.1038/mp.2015.12

Abstract | Full Text | PDF

Dietary glycemic index modulates the behavioral and biochemical abnormalities associated with autism spectrum disorder

A Currais, C Farrokhi, R Dargusch, M Goujon-Svrzic and P Maher

Mol Psychiatry 2016 21: 426-436; advance online publication, June 9, 2015; 10.1038/mp.2015.64

Abstract | Full Text | PDF

Genetic link between family socioeconomic status and children’s educational achievement estimated from genome-wide SNPs OPEN

E Krapohl and R Plomin

Mol Psychiatry 2016 21: 437-443; advance online publication, March 10, 2015; 10.1038/mp.2015.2

Abstract | Full Text | PDF

Erratum

Top

Gene expression in major depressive disorder

R Jansen, B W J H Penninx, V Madar, K Xia, Y Milaneschi, J J Hottenga, A R Hammerschlag, A Beekman, N van der Wee, J H Smit, A I Brooks, J Tischfield, D Posthuma, R Schoevers, G van Grootheest, G Willemsen, E J de Geus, D I Boomsma, F A Wright, F Zou, W Sun and P F Sullivan

Mol Psychiatry 2016 21: 444; advance online publication, June 23, 2015; 10.1038/mp.2015.94

Full Text | PDF

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Molecular Psychiatry. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: